Incyte (INCY)
Create an Alert
20.38
-1.03 -4.81%
NASDAQ
Jun 19, 4:56PM
BATS Real time
Currency in USD
Incyte Revenue Quarterly YoY Growth:
96.46% for March 31, 2013Incyte Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 96.46% |
| Dec. 31, 2012 | 294.1% |
| Sept. 30, 2012 | 260.5% |
| June 30, 2012 | 414.8% |
| March 31, 2012 | 13.15% |
| Dec. 31, 2011 | -66.36% |
| Sept. 30, 2011 | -0.53% |
| June 30, 2011 | -66.27% |
| March 31, 2011 | 84.94% |
| Dec. 31, 2010 | 1151% |
| Sept. 30, 2010 | 1697% |
| June 30, 2010 | 6218% |
| March 31, 2010 | 2476% |
| Dec. 31, 2009 | 632.0% |
| Sept. 30, 2009 | -11.50% |
| June 30, 2009 | 28.50% |
| March 31, 2009 | -48.66% |
| Dec. 31, 2008 | -90.38% |
| Sept. 30, 2008 | -84.14% |
| June 30, 2008 | -94.19% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
INCY Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Jazz Pharmaceuticals | 91.39% |
| Santarus | 73.15% |
| Cubist Pharmaceuticals | 8.61% |
INCY Revenue Quarterly YoY Growth Rankings
| Overall |
97th percentile 405 of 16782 |
| Sector |
94th percentile 79 of 1410 in Healthcare |
| Industry |
92nd percentile 36 of 454 in Biotechnology |
INCY Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -94.19% | Jun 2008 |
| Maximum | 6218% | Jun 2010 |
| Average | 645.2% |
